Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$146.52 - $269.56 $139,780 - $257,160
-954 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$248.56 - $389.34 $22,370 - $35,040
-90 Reduced 8.62%
954 $258,000
Q3 2021

Nov 09, 2021

BUY
$249.6 - $403.14 $15,225 - $24,591
61 Added 6.21%
1,044 $379,000
Q2 2021

Aug 16, 2021

BUY
$292.75 - $367.01 $8,197 - $10,276
28 Added 2.93%
983 $337,000
Q1 2021

May 14, 2021

BUY
$260.64 - $382.12 $248,911 - $364,924
955 New
955 $332,000
Q4 2020

Feb 03, 2021

SELL
$221.31 - $316.61 $716,380 - $1.02 Million
-3,237 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$189.18 - $286.44 $47,295 - $71,610
250 Added 8.37%
3,237 $927,000
Q2 2020

Jul 28, 2020

BUY
$123.9 - $195.41 $35,807 - $56,473
289 Added 10.71%
2,987 $563,000
Q1 2020

Apr 30, 2020

BUY
$121.84 - $173.19 $16,082 - $22,861
132 Added 5.14%
2,698 $332,000
Q4 2019

Feb 14, 2020

BUY
$115.78 - $208.34 $38,323 - $68,960
331 Added 14.81%
2,566 $425,000
Q3 2019

Oct 30, 2019

BUY
$120.61 - $148.29 $13,990 - $17,201
116 Added 5.47%
2,235 $274,000
Q2 2019

Aug 05, 2019

SELL
$113.99 - $146.86 $7,181 - $9,252
-63 Reduced 2.89%
2,119 $263,000
Q1 2019

May 06, 2019

BUY
$122.82 - $151.83 $6,632 - $8,198
54 Added 2.54%
2,182 $288,000
Q4 2018

Feb 12, 2019

BUY
$107.01 - $175.15 $227,717 - $372,719
2,128 New
2,128 $298,000

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $19.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.